Insider Transactions in Q1 2022 at Alimera Sciences Inc (ALIM)
Insider Transaction List (Q1 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 08
2022
|
Morgan Stanley > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
250,000
-30.96%
|
$1,000,000
$4.55 P/Share
|
Jan 10
2022
|
Philip Ashman President of Int'l Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
1,175
-3.42%
|
$4,700
$4.65 P/Share
|
Jan 04
2022
|
Richard S Eiswirth Jr President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+15.57%
|
-
|
Jan 04
2022
|
John Philip Jones Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,750
+21.8%
|
-
|
Jan 04
2022
|
Philip Ashman President of Int'l Operations |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+30.38%
|
-
|
Jan 04
2022
|
David Holland Chief Marketing Officer & SVP |
BUY
Grant, award, or other acquisition
|
Direct |
8,750
+17.99%
|
-
|